FDA WARNING_LETTER - Lesa Sverid
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
The FDA and FTC issued a Warning Letter to Ms. Lesa Sverid regarding the marketing of products (O2xygen Force, DMSO Cream, DMSO Roll-on, DMSO Cream w/Aloe, and AlkaLife) on www.neveranoutbreak.com. The FDA determined these products are unapproved new drugs and misbranded.
Violations include: - **Unapproved New Drugs:** Products are marketed with claims to prevent, treat, or cure herpes (HSV 1 and 2), making them drugs under 21 U.S.C. §§ 321(g)(1)(B) and (C). They are "new drugs" (21 U.S.C. § 321(p)) lacking FDA-approved New Drug Applications (NDAs), violating 21 U.S.C. §§ 331(d) and 355(a). - **Misbranding:** - **Lack of Adequate Directions for Use:** Genital herpes is not amenable to self-treatment, so adequate directions for laypersons cannot be provided, violating 21 U.S.C. § 352(f)(1). - **Dangerous to Health:** Claims for prevention/cure of genital herpes may lead consumers to delay appropriate medical treatment, making products dangerous to health and misbranded under 21 U.S.C. § 352(j).
- Company
- Lesa Sverid
- Product Type
- Drugs
ID · 76a063fc-afd7-456a-a417-cf4132b95c55
Full citation text and observation details available on the Dashboard.